Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
131,516,365
-
Total 13F shares
-
108,175,646
-
Share change
-
+2,618,274
-
Total reported value
-
$11,775,283,696
-
Put/Call ratio
-
88%
-
Price per share
-
$108.85
-
Number of holders
-
311
-
Value change
-
+$281,943,769
-
Number of buys
-
162
-
Number of sells
-
122
Institutional Holders of ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (ALNY) as of Q1 2020
As of 31 Mar 2020 ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (ALNY) had 311 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 108,175,646 shares of stock of the company.
Largest 10 holders included FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, BlackRock Inc., BAILLIE GIFFORD & CO, PRICE T ROWE ASSOCIATES INC /MD/, Dodge & Cox, STATE STREET CORP, Bellevue Group AG, and RTW INVESTMENTS, LP.
This table shows 314 institutional shareholders of the security as of 31 Mar 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.